The stem cell leukemia( SCL) gene is a new oncogene related with leukemogenesis. 干细胞白血病(CL)因是新发现的与白血病发生有关的癌基因。
Alternatiely, leukemias with MLL rearrangement might somehow escape from upregulation of DR4/DR5 and/or downregulation of decoy receptors during leukemogenesis. 或者，带有MLL重排的白血病细胞或许通过某种途径逃避在白血病发生过程中的DR4/DR5的上调或者诱饵受体的下调。
Donor-cell leukemia after allogeneic hematopoietic stem cell transplantation can be an ideal model to investigate the related events in human leukemogenesis. 异基因造血干细胞移植后供者源复发可能是研究人白血病发生的适宜模式。
Homeobox gene in normal hematopoiesis and leukemogenesis 正常造血细胞及白血病细胞中的同源盒基因
Basic and Clinical Studies of the Gene Product-Targeting Therapy Based on Leukemogenesis--Editorial 白血病基因产物靶向治疗的基础和临床研究
Disruption of chromatin remodeling in leukemogenesis and its therapeutic effects 染色质重塑在白血病发病和治疗中的意义
